FRA
MED icon

Front Row Advisors’s Medifast MED Stock Holding History

Front Row Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-44
Closed -$6K – 1083
2018
Q4 		$6K Sell
44
-17
-28% -$2.91K 0.01% 509
2018
Q3 		$12 Hold
61
– – 0.01% 394
2018
Q2 		$11 Hold
61
– – 0.01% 438
2018
Q1 		$6K Sell
61
-7
-10% -$523 ﹤0.01% 533
2017
Q4 		$5K Buy
+68
New +$4.51K ﹤0.01% 537

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Front Row Advisors's MED Position: Q1 2019 in Review

Front Row Advisors sold out of Medifast (MED) in Q1 2019, closing a stake of 44 shares — an estimated $6K sold.

Front Row Advisors first reported a position in MED in Q4 2017 and held it in 5 quarters. The position peaked at $6K in Q4 2018. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

  • Front Row Advisors reported no remaining Medifast position as of Q1 2019 after selling out during the quarter.
  • Front Row Advisors sold 44 Medifast shares in Q1 2019, an estimated $6K.
  • Front Row Advisors first reported a position in Medifast in Q4 2017 and held it in 5 quarters.
  • Front Row Advisors's Medifast position peaked at $6K in Q4 2018.
  • 246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on Front Row Advisors's 13F filing for Q1 2019, filed 16 May 2019.